Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype.

Saved in:
Bibliographic Details
Title: Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype.
Authors: Mitra, A.1,2, Fisher, C.1,2, Foster, C. S.3, Jameson, C.2, Barbachanno, Y.2, Bartlett, J.1, Bancroft, E.2, Doherty, R.1, Kote-Jarai, Z.1, Peock, S.4, Easton, D.4, Eeles, R.1 Rosalind.Eeles@icr.ac.uk, IMPACT and EMBRACE Collaborators (CORPORATE AUTHOR)
Source: British Journal of Cancer. 1/29/2008, Vol. 98 Issue 2, p502-507. 6p. 11 Charts.
Database: Academic Search Ultimate
Description
ISSN:00070920
DOI:10.1038/sj.bjc.6604132